Portpharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Portpharma
Largest movements
- Receivables within one year +€90,489
up €90,489 (+57.2%), from €158,067 to €248,556
of which Trade receivables: +€90,303
- Cash +€83,471
up €83,471 (+32.5%), from €256,494 to €339,965
mainly Net result for the year (+€136,837) and Other debts (+€109,936)
- Tangible fixed assets -€57,493
down €57,493 (-9.9%), from €578,021 to €520,527
of which Plant, machinery and equipment: -€30,553
- Other debts +€109,936
up €109,936 (+46.9%), from €234,491 to €344,427
- Debts after one year -€46,044
down €46,044 (-4.3%), from €1.1m to €1.0m
- Reserves +€36,837
up €36,837 (+8.8%), from €418,118 to €454,955
of which Distributable reserves: +€36,837
- Accrued charges and deferred income +€24,772
up €24,772 (+95.0%), from €26,069 to €50,842
- Gross operating margin +€17,873
up €17,873 (+6.6%), from €272,162 to €290,034
- Staff costs +€12,999
up €12,999 (+50.4%), from €25,811 to €38,810
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,898,509 | €2,038,451 | +€139,942 | +7.4% |
| Fixed assets | 21/28 | €1,155,319 | €1,086,946 | -€68,373 | -5.9% |
| Intangible fixed assets | 21 | €39,693 | €28,813 | -€10,880 | -27.4% |
| Tangible fixed assets | 22/27 | €578,021 | €520,527 | -€57,493 | -9.9% |
| Land and buildings | 22 | €501,914 | €471,615 | -€30,298 | -6.0% |
| Plant, machinery and equipment | 23 | €73,916 | €43,363 | -€30,553 | -41.3% |
| Furniture and vehicles | 24 | €2,191 | €5,550 | +€3,359 | +153% |
| Financial fixed assets | 28 | €537,605 | €537,605 | = | 0.0% |
| Current assets | 29/58 | €743,190 | €951,506 | +€208,315 | +28.0% |
| Stocks and contracts in progress | 3 | €200,907 | €218,254 | +€17,346 | +8.6% |
| Stocks | 30/36 | €200,907 | €218,254 | +€17,346 | +8.6% |
| Amounts receivable within one year | 40/41 | €158,067 | €248,556 | +€90,489 | +57.2% |
| Trade receivables | 40 | €150,628 | €240,931 | +€90,303 | +60.0% |
| Other amounts receivable | 41 | €7,438 | €7,625 | +€187 | +2.5% |
| Current investments | 50/53 | €121,872 | €141,576 | +€19,704 | +16.2% |
| Cash at bank and in hand | 54/58 | €256,494 | €339,965 | +€83,471 | +32.5% |
| Deferred charges and accrued income | 490/1 | €5,851 | €3,155 | -€2,696 | -46.1% |
| Total equity and liabilities | 10/49 | €1,898,509 | €2,038,451 | +€139,942 | +7.4% |
| Equity | 10/15 | €438,118 | €474,955 | +€36,837 | +8.4% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €418,118 | €454,955 | +€36,837 | +8.8% |
| Tax-exempt reserves | 132 | €231 | €231 | = | 0.0% |
| Distributable reserves | 133 | €417,887 | €454,724 | +€36,837 | +8.8% |
| Amounts payable | 17/49 | €1,460,391 | €1,563,497 | +€103,105 | +7.1% |
| Amounts payable after more than one year | 17 | €1,080,776 | €1,034,732 | -€46,044 | -4.3% |
| Financial debts | 170/4 | €1,080,776 | €1,034,732 | -€46,044 | -4.3% |
| Amounts payable within one year | 42/48 | €353,546 | €477,924 | +€124,377 | +35.2% |
| Current portion of amounts payable after more than one year | 42 | €40,667 | €40,667 | = | 0.0% |
| Trade debts | 44 | €66,754 | €75,558 | +€8,804 | +13.2% |
| Suppliers | 440/4 | €66,754 | €75,558 | +€8,804 | +13.2% |
| Advances received on contracts in progress | 46 | €240 | €209 | -€31 | -13.1% |
| Taxes, remuneration and social security | 45 | €11,394 | €17,062 | +€5,668 | +49.7% |
| Taxes | 450/3 | €6,147 | €6,154 | +€6 | +0.1% |
| Remuneration and social security | 454/9 | €5,247 | €10,909 | +€5,662 | +108% |
| Other amounts payable | 47/48 | €234,491 | €344,427 | +€109,936 | +46.9% |
| Accrued charges and deferred income | 492/3 | €26,069 | €50,842 | +€24,772 | +95.0% |
| Non-recurring operating income | 76A | - | €211 | +€211 | |
| Remuneration, social security and pensions | 62 | €25,811 | €38,810 | +€12,999 | +50.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €71,540 | €72,373 | +€833 | +1.2% |
| Other operating charges | 640/8 | €4,133 | €4,956 | +€823 | +19.9% |
| Non-recurring operating charges | 66A | - | €65 | +€65 | |
| Gross operating margin | 9900 | €272,162 | €290,034 | +€17,873 | +6.6% |
| Operating profit (loss) | 9901 | €170,678 | €173,830 | +€3,152 | +1.8% |
| Financial income | 75/76B | €4,743 | €7,302 | +€2,559 | +53.9% |
| Recurring financial income | 75 | €4,743 | €7,302 | +€2,559 | +53.9% |
| Financial charges | 65/66B | €31,874 | €31,159 | -€715 | -2.2% |
| Recurring financial charges | 65 | €31,874 | €31,159 | -€715 | -2.2% |
| Profit (loss) for the period before taxes | 9903 | €143,547 | €149,973 | +€6,426 | +4.5% |
| Income taxes | 67/77 | €11,939 | €13,136 | +€1,197 | +10.0% |
| Profit (loss) for the period | 9904 | €131,608 | €136,837 | +€5,229 | +4.0% |
| Profit (loss) for the period to be appropriated | 9905 | €131,608 | €136,837 | +€5,229 | +4.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.